Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMF – Get Free Report) saw a large decrease in short interest during the month of December. As of December 31st, there was short interest totaling 96,149 shares, a decrease of 82.4% from the December 15th total of 546,949 shares. Based on an average daily volume of 18 shares, the short-interest ratio is presently 5,341.6 days. Based on an average daily volume of 18 shares, the short-interest ratio is presently 5,341.6 days.
Shanghai Pharmaceuticals Price Performance
Shares of Shanghai Pharmaceuticals stock remained flat at $1.46 during trading on Monday. The firm’s 50-day simple moving average is $1.52 and its 200-day simple moving average is $1.53. Shanghai Pharmaceuticals has a 52-week low of $1.46 and a 52-week high of $1.53.
Shanghai Pharmaceuticals Company Profile
Shanghai Pharmaceuticals (OTCMKTS: SHPMF) is a leading integrated healthcare company headquartered in Shanghai, China. Established in 1994 through the consolidation of state‐owned pharmaceutical entities, the firm has built a comprehensive business model spanning pharmaceutical distribution, manufacturing and retail pharmacy services. The company’s core distribution network delivers prescription and over‐the‐counter medications, medical devices and healthcare products to hospitals, clinics and community pharmacies across mainland China.
In its manufacturing segment, Shanghai Pharmaceuticals produces active pharmaceutical ingredients (APIs), finished dosage forms and chemical intermediates.
Read More
- Five stocks we like better than Shanghai Pharmaceuticals
- Which stock will the White House buy next?
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump’s Hand-Written Letter Will Shock his Haters
Receive News & Ratings for Shanghai Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
